Corient Private Wealth
OGN icon

Corient Private Wealth’s Organon & Co OGN Stock Holding History

Corient Private Wealth’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Sell
34,248
-936
-3% -$11.2K ﹤0.01% 2283
2026
Q1 		$210K Sell
35,184
-36,455
-51% -$274K ﹤0.01% 2534
2025
Q4 		$512K Buy
71,639
+48,931
+215% +$387K ﹤0.01% 2300
2025
Q3 		$243K Sell
22,708
-17,592
-44% -$173K ﹤0.01% 2251
2025
Q2 		$390K Sell
40,300
-38,939
-49% -$402K ﹤0.01% 1837
2025
Q1 		$1.18M Buy
79,239
+9,977
+14% +$153K ﹤0.01% 1213
2024
Q4 		$1.03M Sell
69,262
-32,321
-32% -$527K ﹤0.01% 1309
2024
Q3 		$1.94M Buy
101,583
+22,244
+28% +$461K ﹤0.01% 1111
2024
Q2 		$1.64M Buy
79,339
+6,276
+9% +$125K ﹤0.01% 1113
2024
Q1 		$1.37M Sell
73,063
-3,337
-4% -$57.3K ﹤0.01% 1200
2023
Q4 		$1.1M Sell
76,400
-15,285
-17% -$208K ﹤0.01% 1247
2023
Q3 		$1.59M Sell
91,685
-7,839
-8% -$163K ﹤0.01% 1001
2023
Q2 		$2.07M Buy
99,524
+43,259
+77% +$940K ﹤0.01% 886
2023
Q1 		$1.32M Buy
56,265
+9,765
+21% +$262K ﹤0.01% 987
2022
Q4 		$1.3M Buy
+46,500
New +$1.19M ﹤0.01% 832

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Corient Private Wealth's OGN Position: Q2 2026 in Review

Corient Private Wealth reduced its Organon & Co (OGN) stake by 2.7% in Q2 2026, selling an estimated $11.2K and leaving 34,248 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #2283.

Corient Private Wealth first reported a position in OGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.07M in Q2 2023. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Corient Private Wealth held 34,248 shares of Organon & Co worth $464K as of Q2 2026.
  • Corient Private Wealth sold 936 Organon & Co shares in Q2 2026, an estimated $11.2K.
  • Organon & Co made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2283 holding.
  • Corient Private Wealth first reported a position in Organon & Co in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Organon & Co position peaked at $2.07M in Q2 2023.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.